A core clinical trial objective is determining whether a therapy actually improves patient outcomes compared to standard care or placebo. These trials often measure endpoints such as symptom reduction, disease progression delay, or survival outcomes. Late-phase trials generate the evidence required for regulatory approval and clinical adoption.

Current research also focuses on precision medicine — tailoring therapies based on molecular or genetic characteristics. For example, biomarker-driven trials can identify which patient groups are most likely to benefit from specific therapies, improving both success rates and patient safety.